Ophthalmic Imaging Systems Inc. reported consolidated earnings results for the third quarter and nine months ended September 30, 2009. For the three months ended September 30, 2009, the company reported a net revenue increase of 24% to $3.9 million compared to $3.2 million for the same period in 2008. The increase in revenue is due to an increase in product sales of approximately $668,000 and an increase in service revenue of approximately $91,000. Net income for the quarter ended September 30, 2009 was $86,000 compared with a net loss for the quarter ended September 30, 2008 of $416,000 or $0.02 per basic and diluted share. The company reported income from operations of $148,707, net income before income taxes of $88,026 against loss from operations of $372,331, net loss before income taxes of $413,656 for the same period a year ago. For the nine months ended September 30, 2009, the company reported net revenues of $9.2 million, compared with net revenues of $9.5 million for the same period in 2008. The decrease in revenues is due to a decrease of product sales of approximately $617,000, which was partially offset by an increase in service revenue of approximately $374,000. Net loss for the nine months ended September 30, 2009 was $5.0 million, or $0.25 per basic and diluted share, compared to the net loss for the nine months ended September 20, 2008 of $1.1 million, or $0.07 per basic and diluted share. The increase in net loss is mainly attributable to the impairment of debt related to accounts receivable, notes receivable, prepaid products and exclusivity rights of $4.4 million from MediVision Medical Imaging, Ltd., OIS' former parent company and current major shareholder, amortization of research and development from the past of $0.5 million, offset by settlement income received of $1.2 million. The company reported loss from operations of $6,021,482, net loss before income taxes of $5,021,814 against loss from operations of $1,090,364, net loss before income taxes of $1,142,590 for the same period a year ago.

Ophthalmic Imaging Systems Inc. announced that shareholders have executed written consents in lieu of a meeting to approve an amendment to Articles of Incorporation as amended to increase the number of authorized shares of common stock from 35,000,000 shares to 100,000,000 shares.

Ophthalmic Imaging Systems Inc. announced that it will launch two new products and improvements to the OIS EMR and OIS PM solutions at the American Academy of Ophthalmology's (AAO) 113th Annual Meeting, being held October 24 - 27, 2009, at the Moscone Convention Center in San Francisco, CA. OIS EyeScan -- The OIS EyeScan is a revolutionary new portable imaging device that is capable of imaging both the anterior and posterior segment of the eye. This innovative device will allow physicians and other eye professionals the portability and wide ranging functionality to deal with rising demand due to aging and the increase in diabetic related eye disease. Powered by the market leading OIS WinStation Software, and fully integrated with the OIS Symphony Image Management Solution, OIS EyeScan will deliver more functionality than has ever been available in an imaging device. 510(k) pending - not available for sale in the U.S. at the time of this release. OIS Symphony Digital Reporter - By utilizing Digital Reporter with OIS' market leading OIS Symphony Web Image Management System, large institutions will be able to document ophthalmic-specific data that their HIS cannot record; and small practices will be able to obtain certain EMR functionalities without a full EMR system. This combined solution will help the users of digital documentation expand the use of these solutions and streamline their operations which will effectively increase their productivity.